Other News

Vivasure Medical Begins Clinical Evaluation of Next-Generation PerQseal+ Device

First patient enrolled in Frontier V study evaluating enhanced fully absorbable, patch-based large-bore percutaneous closure device GALWAY, Ireland–(BUSINESS WIRE)–Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the first patient was enrolled in the Frontier V study, a European multicenter study evaluating PerQseal®+, the […]

Newly Formed Company, atHeart Medical, Aims to Evolve Septal Closure with the reSept™ ASD Occluder

Company prepares for U.S. IDE clinical trial of its novel metal-free frame designed to reduce complications and preserve long-term treatment options BAAR, Switzerland and MOUNTAIN VIEW, Calif., April 20, 2021 /PRNewswire/ — atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), announced today that […]

Ra Medical Systems Provides Enrollment Update for its Pivotal Atherectomy Clinical Trial

42 total subjects enrolled as of April 19, 2021 12 subjects enrolled since mid-March CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces an increase in enrollment in its pivotal clinical trial to […]

MyoStrain® Provides Comprehensive Assessment of Myocardial Deformation to Help Physicians Risk-Stratify Heart Failure Patients for Individualized Cardiac Treatment

MyoStrain provided a uniquely sensitive and reproducible measure of segmental heart function to help physicians quantify differences in heart failure patients and risk-stratify patient populations based on the individual extent and severity of dysfunction MORRISVILLE, N.C., April 19, 2021 /PRNewswire/ — A new article published in the European Society of Cardiology (ESC) Heart […]

Zynex Appoints Donald Gregg as Vice President of Sales and Operations of Monitoring Solutions Division

ENGLEWOOD, Colo., April 20, 2021 /PRNewswire/ — Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced that it has hired Donald Gregg as the Vice President of Sales and Operations of its Monitoring Solutions Division. In […]

IN.PACT™ AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions

IN.PACT AV Access Trial 24 Month Results Presented as a Podium First at Charing Cross Symposium DUBLIN and LONDON, April 20, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the safety and effectiveness results through 24 months for the IN.PACT AV Access clinical study. The data, which were […]

Quantum Genomics Announces the End of its Collaboration with Qilu for the Development and Commercialization of Firibastat in China

PARIS and NEW YORK, April 20, 2021 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly targets the brain to treat difficult-to-treat and resistant hypertension and heart failure, announces the end of its collaboration with Chinese Pharma […]

SANUWAVE® Rebrands to Reflect Evolved Wound Care Solutions

“Energy First” Protocol Improves Clinical Outcomes SUWANEE, Ga.–(BUSINESS WIRE)–SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, today announced its rebranding. The new brand reflects the evolution of […]

LivaNova Receives FDA 510(k) Clearance for B-Capta, the New In-Line, Blood-Gas Monitoring System Integrated Into the S5 Heart-Lung Machine

Intuitive, optical-based technology system now available around the world LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for B-Capta®, the new in-line, blood-gas monitoring system integrated into the market-leading S5® heart-lung machine (HLM). The system is […]